Bortecad – Bortezomib Injection
Description
BORTEZOMIB (BORTECAD) INJECTION – TREATMENT OF NUMEROUS MYELOMA AND MANTLE-CELL LYMPHOMA
Bortezomib Bortecad Injection is used to treat multiple myeloma and mantle-cell lymphoma. It works by preventing or slowing the formation of cancerous growth cells.
How is Bortezomib 2.5mg Bortecad Injection used?
Bortezomib Bortecad Injection is administered intravenously by a licensed clinical specialist. Your PCP will determine which percentage is important and how frequently you should take it. This will vary depending on what you are being treated for and may change from time to time. You should take it exactly as prescribed by your primary care physician. Misinterpretation or overdose might have severe consequences.
Bortezomib 2.5mg Bortecad Injection Side Effects:
Weakness, queasiness, retching, and loss of craving are some of the most common side effects of this medicine. During the treatment, you may be encouraged to consume a lot of liquids on a regular basis. You should not drive or operate heavy machinery since the medicine may cause drowsiness and wooziness. This medicine may reduce the number of platelets (red blood and white platelets) in your blood, increasing your vulnerability to diseases.
If you have any liver, renal, coronary illness, or draining difficulties, consult your doctor before taking Bortecad 2.5mg Injection. It is vital to consult a doctor if you develop symptoms such as cognitive impairment or difficulty reasoning. Many other prescriptions can influence or be influenced by this medication, so inform your medical care team about all medications you are taking. This drug is not recommended for use during pregnancy or while breastfeeding.
